Señales en vivo de BCAB | Maximiza tus Ganancias con Getagraph.com

VENDER 108678 min ago

@ $2.35

Emitido: 14 feb 2024 @ 09:33

Retorno: 9.79%

Señal anterior: feb 12 - 10:14

Señal anterior: Comprar

Retorno: -12.31 %

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 16:00):

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer...

Stats
Volumen de hoy	465 712
Volumen promedio	550 124
Capitalización de mercado	124.11M
EPS	$0 ( 2024-03-26 )
Próxima fecha de ganancias	( $-0.570 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.000
ATR14	$0.00400 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Smith Scott Andrew	Sell	2 181	Common Stock
2024-03-31	Sievers Eric	Sell	572	Common Stock
2024-02-29	Smith Scott Andrew	Sell	2 181	Common Stock
2024-02-29	Sievers Eric	Sell	572	Common Stock
2024-02-15	Waldron Richard A	Buy	106 000	Common Stock

INSIDER POWER
93.82
Last 100 transactions
Buy: 3 003 180 \| Sell: 92 181

Volumen Correlación

Largo: -0.12 (neutral)

Corto: -0.20 (neutral)

Signal:(55.149) Neutral

BioAtla, Inc. Correlación

10 Correlaciones Más Positivas
GOSS	0.966
ODT	0.962
SWAV	0.95
TRVN	0.944
XFOR	0.944
THTX	0.941
PAVM	0.935
LYRA	0.933
TCDA	0.931
ENPH	0.931

10 Correlaciones Más Negativas
MLCO	-0.965
ITMR	-0.954
AVEO	-0.95
CCRC	-0.946
TOUR	-0.946
LUNA	-0.941
ACAB	-0.938
TCMD	-0.937
RXDX	-0.937
ALXN	-0.937

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioAtla, Inc. Correlación - Moneda/Commodity

-0.60
( weak negative )

-0.64
( weak negative )

0.00
( neutral )

0.78
( moderate )

BioAtla, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-1.22M (0.00 %)
EPS:	$-2.58

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-1.22M (0.00 %)
EPS:	$-2.58

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-1.20M (0.00 %)
EPS:	$-2.70

FY	2021
Ingresos:	$250 000
Beneficio Bruto:	$250 000 (100.00 %)
EPS:	$0

Financial Reports:

No articles found.

BioAtla, Inc.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.